In 10 seconds? CAR-T cell therapies have been very effective in treating a variety of leukemias and lymphomas. Recently, new formulations of CAR-T cells have proven successful against another type of blood cancer called multiple m...
In 10 seconds? Bi-specific T cell engagers, or BiTEs, are cutting-edge cancer treatments that are having success in treating some types of blood cancers. Exciting new data on next-generation formulations of these treatments show t...
In 10 seconds? Excess body weight is a growing cause of cancer worldwide. The number of these cancers increased 34% in the last decade! Scientists are working to better understand this issue and come up with solutions. I guess th...
In 10 seconds? Scientists have developed a method that could be useful in identifying new tumor drug targets on the surface of tumor cells–which they have dubbed ‘the surfaceome’. Why torture my tongue with this? What the heck is...
In 10 seconds? Cancer specialists are actively testing out combinations of treatments to improve patient survival outcomes. Data from a study testing out chemotherapy plus stem cell transplantation for myeloma patients are making...
Recent studies support thalidomide’s use against blood cancers like multiple myeloma (MM) and suggest that the drug can help target cancer-promoting agents that were previously drug resistant. Additionally, it produced better surv...